What is the name of the vaccine for AIDS?
HIV vaccine is a therapeutic vaccine designed to stimulate an immune response against a variety of HIV antigens in patients with HIV. It consists of a suspension of killed HIV-1 virus particles. Remune is not currently FDA approved. HIV vaccine is available under the following different brand names: Remune.
What was the first AIDS vaccine?
1987. The first HIV vaccine clinical trial opened at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. This Phase 1 trial enrolled 138 healthy, HIV-negative volunteers. The gp160 subunit vaccine showed no serious adverse effects.
Is PrEP a vaccine?
No. PrEP medication does not work the same way as a vaccine. When you take a vaccine, it trains the body's immune system to fight off infection for years. You will need to take a pill every day by mouth for PrEP medications to protect you from infection.
1984
1987
- However, scientists are working to develop one. Building on the findings of an earlier study that found for the first time, albeit modestly, that a vaccine could prevent HIV infection in 2016, an NIH-supported clinical trial was launched to test a modified HIV vaccine. This current vaccine trial, c…
1988
1992
1998
1999
- The first HIV vaccine clinical trial opened at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. This Phase 1 trial enrolled 138 healthy, HIV-negative volunteers. The gp160 subunit vaccine showed no serious adverse effects.
2000
- The NIAID AIDS Vaccine Evaluation Group (AVEG), the first U.S. cooperative HIV vaccine clinical trials group, began enrolling volunteers in its first trial.
2003
- NIAID launched the first Phase 2 HIV vaccine clinical trial. This trial included HIV-negative volunteers with a history of high-risk behavior -- injection drug use, multiple sex partners, or sexually transmitted infections. Participants were counseled repeatedly to avoid any behaviors that put them at risk of HIV infection.
2009
- The first annual HIV Vaccine Awareness Day to honor vaccine study volunteers was observed. The first large-scale HIV vaccine trial began. VaxGen initiated a Phase 3 trial of AIDSVAX (VAX004) in North America and the Netherlands involving more than 5,400 volunteers.
2010
- NIAID began the first African preventive HIV vaccine trial in Uganda. The first large-scale HIV vaccine trial in a developing country began. VaxGen initiated a Phase 3 trial of AIDSVAX (VAX003) involving over 2,500 volunteers in Thailand. The newly established Vaccine Research Center (VRC) was dedicated to immunization advocates Dale and Betty Bump...